Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 47 (HMGB1P47) is a processed pseudogene related to the high mobility group box 1 (HMGB1) gene. As a pseudogene, HMGB1P47 does not encode a functional protein, and there is no evidence linking it to recognized biological functions, disease roles, therapeutic targeting, or drug interaction. Pseudogenes are typically regarded as non-functional remnants of protein-coding genes and are not considered therapeutic targets[1][4]. There are no commonly used aliases or alternative names beyond its formal nomenclature. Its only known classification is as a processed pseudogene[1][4]. **Key notes:** - HMGB1P47 is NOT a receptor, enzyme, transporter, or recognized molecular target in biomedical research or clinical practice[1][4]. - This entry is inappropriate as a drug target due to its status as a pseudogene[1][4]. - The functional HMGB1 protein, not the pseudogene, is of extensive biomedical relevance[3]; make sure to distinguish between the two.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 47 (HMGB1P47).